Company
Fortress Biotech, Inc. (FBIO)
Standardized SEC financial data for Fortress Biotech, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001429260 · NASDAQ · Pharmaceutical Preparations.
Gross margin
66.9%
Operating margin
-111.0%
Net margin
10.8%
Revenue growth (YoY)
9.7%
Return on equity
11.0%
ROIC
-157.5%
Free cash flow
-$65.8M
Debt / equity
0.84×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $45.6M | $68.8M | $75.7M | $84.5M | $57.7M | $63.3M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $235.0M | $308.0M | $181.0M | $83.4M | $58.8M | $80.6M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$83.7M | -$116.5M | -$179.4M | -$128.2M | -$80.2M | -$65.8M |
| Capital expenditures |
Get FBIO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/FBIO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/FBIO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"